☆ 4.7 Article

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease

CARDIOVASCULAR DIABETOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease

Eun-Seok Shin et al.

Summary: This study investigated the impact of drug-coated balloon (DCB) treatment on percutaneous coronary intervention for multivessel coronary artery disease (CAD). The results showed that the DCB-based treatment approach reduced stent burden and had a lower rate of adverse cardiovascular events compared to the DES-only treatment.

JACC-CARDIOVASCULAR INTERVENTIONS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry

Jason Nogic et al.

Summary: Diabetes mellitus (DM) is an independent predictor of early stent thrombosis (ST), major adverse cardiovascular events (MACE), and mortality at 30 days in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Additional therapeutic strategies are needed to reduce the risk of early complications in these patients.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus

Doyeon Hwang et al.

Summary: This study investigated the clinical impact of angiographic complete revascularization in patients with diabetes mellitus (DM). The results showed that complete revascularization was beneficial for DM patients after three years of follow-up. Relieving residual disease was more critical for DM patients than for non-DM patients.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of de novo Chronic Total Occlusions

Eun Jung Jun et al.

Summary: This retrospective study evaluated the outcomes of drug-coated balloon (DCB) only treatment for de novo coronary chronic total occlusion (CTO). The results showed that if the revascularization using balloon angioplasty is successful, DCB only treatment of de novo CTOs at the 2-year follow-up has encouraging clinical outcomes, with a low rate of hard endpoints and acceptable MACE rates.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium

Ae-Young Her et al.

Summary: The PTRG-DES consortium aims to assess the impact of platelet function test (PFT) results and genotype on long-term clinical outcomes in East Asian patients with coronary artery disease. The study found that high platelet reactivity and specific genotypes related to clopidogrel responsiveness were common in Korean patients during dual antiplatelet therapy. These findings have important implications for developing optimal antiplatelet regimens.

YONSEI MEDICAL JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Eline H. Ploumen et al.

Summary: The study found that both diabetic patients and prediabetic patients are at a higher cardiovascular risk after treatment with new-generation DES. The risks of ischemic and bleeding events were higher in both patient groups, with differences in major bleeding potentially attributed to baseline characteristics. Routine assessment of glycemic state could help identify prediabetic patients for intensified management of cardiovascular risk factors.

CARDIOVASCULAR DIABETOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group

Ae-Young Her et al.

Summary: Coronary artery disease is the leading cause of death globally, and drug-coated balloon (DCB) treatment has shown promising results in addressing metal stent-related restenosis and other coronary artery diseases, with potential for wider application.

CARDIOLOGY JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents The BASKET-SMALL 2 Trial

Jochen Woehrle et al.

Summary: This study evaluated the impact of diabetes on clinical outcomes in patients receiving DCB or DES treatment for de novo lesions. The study found that rates of major adverse cardiac events were similar between DCB and DES in both diabetic and nondiabetic patients, but diabetic patients had significantly lower rates of target vessel revascularization with DCB compared to DES.

JACC-CARDIOVASCULAR INTERVENTIONS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Drug-Coated Balloons for Coronary Artery Disease

Raban V. Jeger et al.

JACC-Cardiovascular Interventions (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

2018 ESC/EACTS Guidelines on myocardial revascularization

Miguel Sousa-Uva et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis

Kazuyuki Yahagi et al.

NATURE REVIEWS CARDIOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity Patient-Level Pooled Analysis of 6081 Patients

Konstantinos C. Koskinas et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)

Add to Collection

Article Multidisciplinary Sciences

Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study

Soe Hee Ann et al.

PLOS ONE (2016)

Add to Collection

Article Medicine, General & Internal

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

Seung-Jung Park et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

Joshua A. Beckman et al.

EUROPEAN HEART JOURNAL (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease A Pooled Analysis of 5775 Individual Patient Data

Duk-Woo Park et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)

Add to Collection

Article Medicine, General & Internal

Strategies for Multivessel Revascularization in Patients with Diabetes

Michael E. Farkouh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium

Roxana Mehran et al.

CIRCULATION (2011)

Add to Collection

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Studies Comparing Coronary Artery Bypass Grafting With Drug-Eluting Stenting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Michael S. Lee et al.

AMERICAN JOURNAL OF CARDIOLOGY (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Stent Thrombosis

David R. Holmes et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials

Mark A. Hlatky et al.

LANCET (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients - The EVASTENT matched-cohort registry

Jacques Machecourt et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients

Lisette Okkels Jensen et al.

EUROPEAN HEART JOURNAL (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical end points in coronary stent trials - A case for standardized definitions

Donald E. Cutlip et al.

CIRCULATION (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.